SCHEMBL1899679

SCHEMBL1899679

CCC(C(=O)O)n1c2c(c3cc(F)ccc31)C[C@H](NC(=O)CCc1ccc(OC)cc1)CC2

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 9/20 0.47
TP53 P04637 1/20 0.42
NAAA Q02083 1/20 0.41
HRH1 P35367 1/20 0.41
HTR6 P50406 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899681 1.00 PTGDR2 (0.47) PTGDR2TP53NAAAHRH1HTR6
SCHEMBL1903248 1.00 PTGDR2 (0.47) PTGDR2TP53NAAAHRH1HTR6
SCHEMBL1900419 0.94 PTGDR2 (0.51) PTGDR2MTNR1AMTNR1BCYP2C9
SCHEMBL2490234 0.94 PTGDR2 (0.51) PTGDR2MTNR1AMTNR1BCYP2C9
SCHEMBL2492915 0.93 PTGDR2 (0.49) PTGDR2HRH1HTR6MTNR1AMTNR1B
SCHEMBL1903101 0.93 PTGDR2 (0.49) PTGDR2HRH1HTR6MTNR1AMTNR1B
SCHEMBL1903098 0.93 PTGDR2 (0.49) PTGDR2HRH1HTR6MTNR1AMTNR1B
SCHEMBL1901602 0.92 PTGDR2 (0.49) PTGDR2MTNR1AMTNR1BCYP2C9
SCHEMBL1901604 0.92 PTGDR2 (0.49) PTGDR2MTNR1AMTNR1BCYP2C9
SCHEMBL1903427 0.92 PTGDR2 (0.47) PTGDR2MTNR1AMTNR1BCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051962-B1 (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2011-10-26 EP disclosed
EP-2316824-A1 (3-Amino-1,2,3,4-tetrahydro-9H-carbazoI-9-yl)-acetic acid derivates Actelion Pharmaceuticals Ltd. (CH) 2011-05-04 EP disclosed